|
US1722496A
(en)
|
1926-07-29 |
1929-07-30 |
William B Chapman |
Boiler and method of operating the same
|
|
US1725396A
(en)
|
1927-05-16 |
1929-08-20 |
Int Harvester Co |
Plow
|
|
US1725496A
(en)
|
1927-12-27 |
1929-08-20 |
John R Ketchum |
Oil-well pump
|
|
US2821696A
(en)
|
1953-11-25 |
1958-01-28 |
Hughes Aircraft Co |
Electronic multiple comparator
|
|
JPS5612114B2
(enExample)
|
1974-06-07 |
1981-03-18 |
|
|
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
|
MX7065E
(es)
|
1980-06-06 |
1987-04-10 |
Sankyo Co |
Un procedimiento microbiologico para preparar derivados de ml-236b
|
|
US4450171A
(en)
*
|
1980-08-05 |
1984-05-22 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
US4448784A
(en)
|
1982-04-12 |
1984-05-15 |
Hoechst-Roussel Pharmaceuticals, Inc. |
1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof
|
|
US4499289A
(en)
*
|
1982-12-03 |
1985-02-12 |
G. D. Searle & Co. |
Octahydronapthalenes
|
|
CA1327360C
(en)
|
1983-11-14 |
1994-03-01 |
William F. Hoffman |
Oxo-analogs of mevinolin-like antihypercholesterolemic agents
|
|
US4613610A
(en)
|
1984-06-22 |
1986-09-23 |
Sandoz Pharmaceuticals Corp. |
Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
|
|
US4686237A
(en)
*
|
1984-07-24 |
1987-08-11 |
Sandoz Pharmaceuticals Corp. |
Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
|
|
US4647576A
(en)
*
|
1984-09-24 |
1987-03-03 |
Warner-Lambert Company |
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
|
|
WO1986003488A1
(en)
|
1984-12-04 |
1986-06-19 |
Sandoz Ag |
Indene analogs of mevalonolactone and derivatives thereof
|
|
US4668794A
(en)
|
1985-05-22 |
1987-05-26 |
Sandoz Pharm. Corp. |
Intermediate imidazole acrolein analogs
|
|
HUT48208A
(en)
|
1985-10-25 |
1989-05-29 |
Sandoz Ag |
Process for producing heterocyclic analogues of mevalolactone derivatives and pharmaceutical compositions comprising such compounds
|
|
FR2596393B1
(fr)
|
1986-04-01 |
1988-06-03 |
Sanofi Sa |
Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
|
|
US4716175A
(en)
|
1987-02-24 |
1987-12-29 |
Warner-Lambert Company |
Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
|
|
GR1000959B
(el)
|
1987-05-22 |
1993-03-16 |
Squibb & Sons Inc |
ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ ΡΕΔΟΥΚΤΑΣΗΣ HMG-CοA ΠΟΥ ΠΕΡΙΕΧΕΙ ΦΩΣΦΟΡΟ,ΝΕΑ ΕΝΔΙΑΜΕΣΑ ΚΑΙ ΜΕΘΟΔΟΣ
|
|
US5015644A
(en)
|
1987-06-02 |
1991-05-14 |
Warner-Lambert Company |
Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
|
|
US4924024A
(en)
|
1988-01-11 |
1990-05-08 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing squalene synthetase inhibitors, new intermediates and method
|
|
US4871721A
(en)
|
1988-01-11 |
1989-10-03 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing squalene synthetase inhibitors
|
|
NO177005C
(no)
|
1988-01-20 |
1995-07-05 |
Bayer Ag |
Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
|
|
KR930005040B1
(ko)
*
|
1989-08-31 |
1993-06-12 |
주식회사 금성사 |
식기 건조기 겸용 전자레인지 및 그 구동제어방법
|
|
US5026554A
(en)
|
1990-09-13 |
1991-06-25 |
Merck & Co., Inc. |
Method of inhibiting fungal growth using squalene synthetase inhibitors
|
|
US5595872A
(en)
*
|
1992-03-06 |
1997-01-21 |
Bristol-Myers Squibb Company |
Nucleic acids encoding microsomal trigyceride transfer protein
|
|
HU218419B
(hu)
|
1992-03-06 |
2000-08-28 |
E.R. Squibb And Sons, Inc. |
Mikroszomális triglicerid transzfer protein (MTP) nagy molekulatömegű alegységének rekombináns úton történő előállítására és a protein és inhibitorainak kimutatására szolgáló eljárások
|
|
US5470845A
(en)
*
|
1992-10-28 |
1995-11-28 |
Bristol-Myers Squibb Company |
Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
|
|
US5739135A
(en)
|
1993-09-03 |
1998-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5631365A
(en)
*
|
1993-09-21 |
1997-05-20 |
Schering Corporation |
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
DE4435477A1
(de)
*
|
1994-10-04 |
1996-04-11 |
Bayer Ag |
Cycloalkano-indol- und -azaindol-derivate
|
|
US5510379A
(en)
|
1994-12-19 |
1996-04-23 |
Warner-Lambert Company |
Sulfonate ACAT inhibitors
|
|
US5536859A
(en)
|
1995-02-27 |
1996-07-16 |
Amoco Corporation |
Alpha-olefin catalyst and process
|
|
GB9504066D0
(en)
|
1995-03-01 |
1995-04-19 |
Pharmacia Spa |
Phosphate derivatives of ureas and thioureas
|
|
ES2191706T3
(es)
|
1995-06-07 |
2003-09-16 |
Pfizer |
Derivados de tetrahidro-isoquinolinil-6-il amida del acido bifenil-2-carboxilico, su preparacion y su uso como inhibidores de la proteina de transferencia de trigliceridos microsomal y/o secrecion de apolipoproteina b (apo b).
|
|
EP0832069B1
(en)
|
1995-06-07 |
2003-03-05 |
Pfizer Inc. |
BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
|
|
DE19546918A1
(de)
*
|
1995-12-15 |
1997-06-19 |
Bayer Ag |
Bicyclische Heterocyclen
|
|
DE19546919A1
(de)
|
1995-12-15 |
1997-06-19 |
Bayer Ag |
N-Heterocyclisch substituierte Phenylessigsäure-Derivate
|
|
DE19613550A1
(de)
|
1996-04-04 |
1997-10-09 |
Bayer Ag |
Neue Pyrimido[1,2-a]indole
|
|
DE19613549A1
(de)
*
|
1996-04-04 |
1997-10-09 |
Bayer Ag |
Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
|
|
US6774236B1
(en)
*
|
1996-04-04 |
2004-08-10 |
Bayer Aktiengesellschaft |
Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
|
|
DE19615265A1
(de)
*
|
1996-04-18 |
1997-12-04 |
Bayer Ag |
Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
|
|
KR20000065152A
(ko)
|
1996-04-30 |
2000-11-06 |
디. 제이. 우드, 스피겔 알렌 제이 |
4'-트리플루오로메틸비페닐-2-카복실산2-(2에이치-[1,2,4]트리아졸-3-일메틸)-1,2,3,4-테트라히드로-이소퀴놀린-6-일-아미드를제조하기위한방법및이의중간체
|
|
US6057339A
(en)
*
|
1996-05-09 |
2000-05-02 |
Bristol-Myers Squibb Company |
Method of inhibiting or treating phytosterolemia with an MTP inhibitor
|
|
US5885983A
(en)
*
|
1996-05-10 |
1999-03-23 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5827875A
(en)
*
|
1996-05-10 |
1998-10-27 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5883109A
(en)
*
|
1996-07-24 |
1999-03-16 |
Bristol-Myers Squibb Company |
Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
|
|
JP2002513379A
(ja)
|
1996-07-24 |
2002-05-08 |
ブリストル―マイヤーズ・スクイブ・カンパニー |
Ｍｔｐ抑制因子を用いる、高ｌｄｌの必要を持つ腫瘍の治療法
|
|
BR9714364A
(pt)
|
1996-11-27 |
2000-03-21 |
Pfizer |
Amidas inibidoras da secreção de apo b/mtp
|
|
US5760246A
(en)
*
|
1996-12-17 |
1998-06-02 |
Biller; Scott A. |
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
|
|
WO1998027979A1
(en)
|
1996-12-20 |
1998-07-02 |
Bristol-Myers Squibb Company |
Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
|
|
EP0989852A4
(en)
|
1997-01-17 |
2002-11-13 |
Bristol Myers Squibb Co |
METHODS FOR TREATING ATHEROSCLEROSE THROUGH AN MPT INHIBITOR AND CHOLESTEROL LEVELS LOWERING MEDICINES
|
|
US6066653A
(en)
|
1997-01-17 |
2000-05-23 |
Bristol-Myers Squibb Co. |
Method of treating acid lipase deficiency diseases with an MTP inhibitor and cholesterol lowering drugs
|
|
WO1998031225A1
(en)
|
1997-01-17 |
1998-07-23 |
Bristol-Myers Squibb Company |
A method of inhibiting or treating phytosterolemia with an mtp inhibitor
|
|
CA2286341A1
(en)
|
1997-05-01 |
1998-11-12 |
John R. Ii Wetterau |
Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
|
|
US5990110A
(en)
*
|
1997-07-15 |
1999-11-23 |
Bristol-Meyers Squibb Company |
Method for treating tumors having high LDL requirements employing MTP inhibitors
|
|
US20030153541A1
(en)
|
1997-10-31 |
2003-08-14 |
Robert Dudley |
Novel anticholesterol compositions and method for using same
|
|
US20020045271A1
(en)
*
|
1998-06-10 |
2002-04-18 |
Licata And Tyrrell P.C. |
Compounds and methods for identifying compounds that interact with microsomal triglyceride transfer protein binding sites on apolipoprotein b and modulate lipid biosynthesis
|
|
EE200100155A
(et)
*
|
1998-09-17 |
2002-08-15 |
Bristol-Myers Squibb Company |
Ateroskleroosi ravimeetod, kasutades aP2 inhibiitorit ja selle kombinatsiooni
|
|
US7358254B2
(en)
|
2001-07-13 |
2008-04-15 |
Bristol-Myers Squibb Company |
Method for treating atherosclerosis employing an aP2 inhibitor and combination
|
|
GT199900147A
(es)
|
1998-09-17 |
1999-09-06 |
|
1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
|
|
US6509348B1
(en)
*
|
1998-11-03 |
2003-01-21 |
Bristol-Myers Squibb Company |
Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
|
|
IL133201A0
(en)
|
1998-12-04 |
2001-03-19 |
Pfizer Prod Inc |
Lowering blood levels of lipoproten (a)
|
|
EA200100704A1
(ru)
|
1998-12-23 |
2002-02-28 |
Джи.Ди.Сирл Ллс |
Комбинация для применения по сердечно-сосудистым показаниям
|
|
US6344450B1
(en)
*
|
1999-02-09 |
2002-02-05 |
Bristol-Myers Squibb Company |
Lactam compounds and their use as inhibitors of serine proteases and method
|
|
JP2002536411A
(ja)
*
|
1999-02-09 |
2002-10-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｘａ因子のラクタム系阻害剤および方法
|
|
DE60018225T2
(de)
*
|
1999-03-01 |
2005-12-29 |
Pfizer Products Inc., Groton |
Oxamsäuren mit einer Cyanogruppe als Liganden für den Thyroidrezeptor
|
|
US6582698B1
(en)
|
1999-03-19 |
2003-06-24 |
Genentech, Inc. |
Treatment method
|
|
EP1117396A1
(en)
|
1999-07-30 |
2001-07-25 |
Hendrik Jan Verkade |
A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces
|
|
DE19951022A1
(de)
|
1999-10-22 |
2001-04-26 |
Bayer Ag |
Carbolinderivate
|
|
IL139450A0
(en)
|
1999-11-10 |
2001-11-25 |
Pfizer Prod Inc |
Methods of administering apo b-secretion/mtp inhibitors
|
|
US6620821B2
(en)
*
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
US6812345B2
(en)
*
|
2000-06-15 |
2004-11-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
US6627636B2
(en)
*
|
2000-06-15 |
2003-09-30 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
DE10030375A1
(de)
*
|
2000-06-21 |
2002-01-03 |
Bayer Ag |
Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
|
|
US6649770B1
(en)
|
2000-11-27 |
2003-11-18 |
Ciba Specialty Chemicals Corporation |
Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof
|
|
IL156552A0
(en)
*
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
|
JP2002220345A
(ja)
|
2001-01-24 |
2002-08-09 |
Sumitomo Pharmaceut Co Ltd |
脂肪肝改善剤
|
|
IL156585A0
(en)
*
|
2001-01-26 |
2004-01-04 |
Schering Corp |
Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
|
|
HRP20031051B1
(en)
*
|
2001-06-28 |
2012-01-31 |
Pfizer Products Inc. |
Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
|
|
US6884812B2
(en)
*
|
2001-08-31 |
2005-04-26 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
|
|
US7056906B2
(en)
*
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
AU2002357137A1
(en)
*
|
2001-12-10 |
2003-06-23 |
Bristol-Myers Squibb Company |
(1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
|
|
TW200301698A
(en)
*
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
US20030162788A1
(en)
*
|
2002-01-10 |
2003-08-28 |
Boehringer Ingelheim Pharma Kg |
Combination of MTP inhibitors or apoB-secretion inhibitors with fibrates for use as pharmaceuticals
|
|
JP3662566B2
(ja)
*
|
2002-02-28 |
2005-06-22 |
日本たばこ産業株式会社 |
エステル化合物及びその医薬用途
|
|
IL161134A0
(en)
*
|
2002-02-28 |
2004-08-31 |
Japan Tobacco Inc |
Ester compound and medical use thereof
|
|
GEP20084475B
(en)
*
|
2002-07-09 |
2008-09-10 |
Bristol Myers Squibb Co |
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method for their production
|
|
RS51053B
(sr)
|
2002-07-23 |
2010-10-31 |
Basf Aktiengesellschaft |
Herbicidne smeše koje deluju sinergetski
|
|
WO2004028544A1
(en)
|
2002-09-25 |
2004-04-08 |
Novo Nordisk A/S |
Use of mas-compounds for treating diseases associated with lipid metabolism
|
|
US20050090426A1
(en)
*
|
2003-03-24 |
2005-04-28 |
Blumberg Richard S. |
Methods of inhibiting inflammation
|
|
US6846836B2
(en)
*
|
2003-04-18 |
2005-01-25 |
Bristol-Myers Squibb Company |
N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
|
|
WO2004110375A2
(en)
|
2003-06-06 |
2004-12-23 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes
|
|
WO2005000217A2
(en)
|
2003-06-06 |
2005-01-06 |
Merck & Co., Inc. |
Combination therapy for the treatment of dyslipidemia
|
|
EP1635773A2
(en)
|
2003-06-06 |
2006-03-22 |
Merck & Co., Inc. (a New Jersey corp.) |
Combination therapy for the treatment of hypertension
|
|
US20040253923A1
(en)
*
|
2003-06-12 |
2004-12-16 |
Braley Richard C. |
System and method for electronically pairing devices
|
|
JP2007508241A
(ja)
|
2003-07-31 |
2007-04-05 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
Ｐｄｅ１０ａ阻害剤を用いる糖尿病および関連障害の処置方法
|
|
WO2005018436A2
(en)
*
|
2003-08-26 |
2005-03-03 |
The Trustees Of Boston University |
Methods for the diagnosis, prognosis and treatment of metabolic syndrome
|
|
EP1669345A4
(en)
*
|
2003-08-29 |
2008-02-20 |
Japan Tobacco Inc |
ESTER DERIVATIVE AND MEDICAL USE THEREOF
|
|
US7153976B2
(en)
|
2003-10-06 |
2006-12-26 |
Pfizer Inc. |
Purification process for an azabicyclo[3.1.0]hexane compound
|
|
EP1522541A1
(en)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Novel hypocholesterolemic compounds
|
|
CA2540978A1
(en)
*
|
2003-10-08 |
2005-04-21 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
|
|
WO2005046662A2
(en)
*
|
2003-11-07 |
2005-05-26 |
Jj Pharma, Inc. |
Hdl-boosting combination therapy complexes
|
|
WO2005051382A1
(ja)
|
2003-11-28 |
2005-06-09 |
Astellas Pharma Inc. |
脂質低下作用増強剤
|
|
JP2007519605A
(ja)
|
2004-01-30 |
2007-07-19 |
日本たばこ産業株式会社 |
食欲抑制薬
|
|
US20070098778A1
(en)
|
2004-03-02 |
2007-05-03 |
Abeille Pharmaceuticals, Inc. |
Co-formulations or kits of bioactive agents
|
|
ES2399721T5
(es)
|
2004-03-05 |
2016-05-25 |
Univ Pennsylvania |
Métodos para tratar trastornos o enfermedades asociados a la hiperlipidemia e hipercolesterolemia minimizando los efectos adversos
|
|
WO2005085466A2
(en)
|
2004-03-09 |
2005-09-15 |
Bayer Healtcare Ag |
Diagnostic and therapeutics for diseases associated with rho-associated protein kinase 2 (rock2)
|
|
GB0405459D0
(en)
|
2004-03-11 |
2004-04-21 |
Shea Clayton O |
Skipping ropes
|
|
WO2005094864A2
(en)
|
2004-03-30 |
2005-10-13 |
Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. |
Treatment of hedgehog- and wnt-secreting tumors with inhibitors of lipoprotein particle biogenesis
|
|
US20080280922A1
(en)
|
2004-04-09 |
2008-11-13 |
Marc Alois Celine Maria Engelen |
Intermittent Dosing Regimen For Overweight and Obese Subjects
|
|
JP4782991B2
(ja)
|
2004-06-30 |
2011-09-28 |
株式会社東芝 |
情報処理機器および情報処理機器の表示制御方法
|
|
CA2571683A1
(en)
*
|
2004-06-30 |
2006-01-12 |
Combinatorx, Incorporated |
Methods and reagents for the treatment of metabolic disorders
|
|
KR20070072888A
(ko)
*
|
2004-10-25 |
2007-07-06 |
니뽄 다바코 산교 가부시키가이샤 |
용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
|
|
JP2008522970A
(ja)
*
|
2004-12-06 |
2008-07-03 |
レリアント ファーマスーティカルズ インコーポレイテッド |
脂質療法用のオメガ−３脂肪酸類及び異常脂質血症薬剤
|
|
SG144145A1
(en)
|
2004-12-08 |
2008-07-29 |
Sirion Therapeutics Inc |
Methods, assays and compositions for treating retinol-related diseases
|
|
US20060252733A1
(en)
|
2005-04-07 |
2006-11-09 |
Novelix Pharmaceuticals, Inc. |
Betulin, betulin derivatives, betulinic acid and betulinic acid derivatives as novel therapeutics in the treatment of disease of lipid and/or glucose metabolism
|
|
WO2006108666A1
(en)
|
2005-04-13 |
2006-10-19 |
Proteosys Ag |
Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
|
|
FR2884831B1
(fr)
|
2005-04-22 |
2007-08-10 |
Merck Sante Soc Par Actions Si |
Methode de criblage de composes inhibiteurs de la mtp
|
|
JP2008542255A
(ja)
*
|
2005-05-27 |
2008-11-27 |
ファイザー・プロダクツ・インク |
肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
|
|
BRPI0616002B1
(pt)
|
2005-09-13 |
2016-04-19 |
Bayer Cropscience Ag |
composto derivado de fenil-amidina, processo de preparação de composto, método de controle de fungos fitopatogênicos de safras e método de controle de insetos daninhos
|
|
EP1948163A2
(en)
|
2005-10-18 |
2008-07-30 |
Aegerion Pharmaceuticals |
Methods for treating disorders associated with hyperlipidemia in a mammal
|
|
KR20080059233A
(ko)
|
2005-10-21 |
2008-06-26 |
노파르티스 아게 |
레닌 억제제, 및 항이상지질혈증제 및/또는 항비만제의조합물
|
|
CA2652751A1
(en)
|
2006-05-18 |
2007-11-29 |
Bayer Healthcare Ag |
Pharmaceutical compositions and methods of using same
|
|
CA2654183A1
(en)
|
2006-06-02 |
2007-12-13 |
San Diego State University Research Foundation |
Compositions and methods for ameliorating hyperlipidemia
|
|
US20090042835A1
(en)
|
2006-06-02 |
2009-02-12 |
Davis Roger A |
Compositions and methods for ameliorating hyperlipidemia
|
|
AU2007260528A1
(en)
|
2006-06-13 |
2007-12-21 |
Merck Frosst Canada Ltd. |
Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US20080016127A1
(en)
|
2006-06-30 |
2008-01-17 |
Microsoft Corporation |
Utilizing software for backing up and recovering data
|
|
DE102006034907A1
(de)
|
2006-07-28 |
2008-01-31 |
Carl Zeiss Microimaging Gmbh |
Laser-Scanning-Mikroskop
|
|
US20080033019A1
(en)
|
2006-08-07 |
2008-02-07 |
Duke University |
Cholesterol lowering drug combination
|
|
US20100310553A1
(en)
|
2006-08-14 |
2010-12-09 |
Guangxiang Luo |
Compositions and Methods for Controlling Hepatitis C Virus Infection
|
|
JP2010502702A
(ja)
|
2006-09-05 |
2010-01-28 |
シェーリング コーポレイション |
脂質管理およびアテローム性動脈硬化症および脂肪肝の治療治療において使用される医薬組成物
|
|
WO2008072061A1
(en)
|
2006-12-14 |
2008-06-19 |
Pfizer Products Inc. |
Method of treatment of obesity with an mtp inhibitor in conjunction with an increased-fat diet
|
|
WO2008075949A1
(en)
|
2006-12-20 |
2008-06-26 |
Friesland Brands B.V. |
Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms
|
|
JP2010513534A
(ja)
|
2006-12-21 |
2010-04-30 |
エージェリオン ファーマシューティカルズ， インコーポレイテッド |
Ｍｔｐインヒビターおよびコレステロール吸収インヒビターを含む組み合わせを用いて肥満症を処置する方法
|
|
US7645732B2
(en)
|
2007-01-24 |
2010-01-12 |
Board Of Regents, The University Of Texas System |
Treating hepatitis C virus infection
|
|
WO2008090198A1
(en)
|
2007-01-25 |
2008-07-31 |
Janssen Pharmaceutica Nv |
Use of mtp inhibitors for increasing levels of satiety hormones
|
|
WO2008115574A1
(en)
|
2007-03-21 |
2008-09-25 |
Reliant Pharmaceuticals, Inc. |
Cb1 antagonist and a dyslipidemic agent and/or metabolic regulator, and methods of making and using same
|
|
FR2922945B1
(fr)
|
2007-10-31 |
2009-11-27 |
Peugeot Citroen Automobiles Sa |
Procede de determination d'intervalle de maintenance pour vehicule automobile.
|
|
WO2010083280A2
(en)
|
2009-01-14 |
2010-07-22 |
Aegerion Pharmaceuticals, Inc. |
Methods for treating obesity and disorders associated with hyperlipidemia in a mammal
|
|
WO2012010212A1
(en)
|
2010-07-23 |
2012-01-26 |
Prysmian S.P.A. |
Bend-resistant single-mode optical fibre
|